Company · CIK 1742927
REVIVA PHARMACEUTICALS HOLDINGS, INC.
| CIK | 1742927 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | RVPH (OTC) |
| First annual or quarterly report | 2018-10-11 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-276848 | 2024-02-02 | 2026-03-19 | 10 | |
| 333-262348 | 2022-01-26 | 2024-12-18 | 8 | |
| 333-267762 | 2022-10-06 | 2023-04-04 | 4 | |
| 333-251802 | 2020-12-29 | 2022-03-22 | 9 | |
| 333-255323 | 2021-04-19 | 2022-03-22 | 7 | |
| 333-226263 | 2018-07-20 | 2018-08-22 | 5 |
Filings
45| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-19 | 424B5Shelf takedown | 333-276848 | 0001437749-26-009062 |
| 2026-03-18 | 424B5Shelf takedown | 333-276848 | 0001437749-26-008843 |
| 2025-09-19 | 424B5Shelf takedown | 333-276848 | 0001437749-25-029530 |
| 2025-09-18 | 424B5Shelf takedown | 333-276848 | 0001437749-25-029398 |
| 2025-06-26 | 424B5Shelf takedown | 333-276848 | 0001437749-25-021353 |
| 2025-06-25 | 424B5Shelf takedown | 333-276848 | 0001437749-25-021260 |
| 2025-05-30 | 424B5Shelf takedown | 333-276848 | 0001437749-25-019011 |
| 2024-12-18 | 424B5Shelf takedown | 333-262348 | 0001437749-24-037758 |
| 2024-12-16 | 424B5Shelf takedown | 333-262348 | 0001437749-24-037646 |
| 2024-08-22 | 424B5Shelf takedown | 333-262348 | 0001437749-24-027562 |
| 2024-05-29 | 424B5Shelf takedown | 333-262348 | 0001437749-24-018516 |
| 2024-02-13 | EFFECTDeclared effective | 333-276848 | 9999999995-24-000430 |
| 2024-02-13 | 424B4Final prospectus | 333-276848 | 0001437749-24-003937 |
| 2024-02-02 | S-3Shelf registered | 333-276848 | 0001437749-24-002961 |
| 2023-11-17 | 424B5Shelf takedown | 333-262348 | 0001437749-23-032462 |
| 2023-04-04 | EFFECTDeclared effective | 333-267762 | 9999999995-23-000816 |
| 2022-10-18 | 424B4Final prospectus | 333-267762 | 0001437749-22-024273 |
| 2022-10-17 | EFFECTDeclared effective | 333-267762 | 9999999995-22-003060 |
| 2022-10-06 | S-1Registration filed | 333-267762 | 0001437749-22-023768 |
| 2022-09-07 | 424B5Shelf takedown | 333-262348 | 0001437749-22-021975 |
| 2022-03-22 | EFFECTDeclared effective | 333-255323 | 9999999995-22-000685 |
| 2022-03-22 | EFFECTDeclared effective | 333-251802 | 9999999995-22-000684 |
| 2022-02-02 | EFFECTDeclared effective | 333-262348 | 9999999995-22-000312 |
| 2022-01-26 | S-3Shelf registered | 333-262348 | 0001437749-22-001694 |
| 2021-05-28 | 424B4Final prospectus | 333-255323 | 0001437749-21-013719 |
| 2021-05-26 | EFFECTDeclared effective | 333-255323 | 9999999995-21-002120 |
| 2021-05-25 | S-1/AAmendment | 333-255323 | 0001437749-21-013217 |
| 2021-05-19 | S-1/AAmendment | 333-255323 | 0001437749-21-012734 |
| 2021-05-17 | 424B4Final prospectus | 333-251802 | 0001437749-21-012528 |
| 2021-05-14 | EFFECTDeclared effective | 333-251802 | 9999999995-21-001938 |
| 2021-05-10 | S-1/AAmendment | 333-255323 | 0001437749-21-011438 |
| 2021-04-19 | S-1Registration filed | 333-255323 | 0001437749-21-009169 |
| 2021-03-29 | 424B4Final prospectus | 333-251802 | 0001437749-21-007450 |
| 2021-03-26 | EFFECTDeclared effective | 333-251802 | 9999999995-21-001159 |
| 2021-01-12 | 424B4Final prospectus | 333-251802 | 0001104659-21-003280 |
| 2021-01-11 | EFFECTDeclared effective | 333-251802 | 9999999995-21-000114 |
| 2021-01-07 | S-1/AAmendment | 333-251802 | 0001104659-21-002049 |
| 2020-12-29 | S-1Registration filed | 333-251802 | 0001104659-20-140190 |
| 2020-11-10 | EFFECTDeclared effective | 333-245057 | 9999999995-20-003117 |
| 2018-08-22 | 424B4Final prospectus | 333-226263 | 0001144204-18-045961 |
| 2018-08-20 | EFFECTDeclared effective | 333-226263 | 9999999995-18-002143 |
| 2018-08-16 | S-1/AAmendment | 333-226263 | 0001144204-18-045184 |
| 2018-08-06 | S-1/AAmendment | 333-226263 | 0001144204-18-042170 |
| 2018-07-20 | S-1Registration filed | 333-226263 | 0001144204-18-039143 |
| 2018-06-19 | DRSDraft made public | 377-02126 | 0001144204-18-034853 |